Statsols Blog

New lung cancer detection instrument moving to clinical trials stage

Owlstone Nanotech, the developers of a promising new lung cancer detection instrument have announced they are now moving their device into clinical trials. The trials are said to begin later this year in a rapid access lung cancer clinic at Glenfield Hospital in Leicester, England.

Topics: News & Events Industry News

nQuery Advisor + nTerim used to calculate sample size at St James Hospital, Dublin.

nQuery Advisor + nTerim was used to calculate sample size in a study conducted at St James Hospital, Dublin. The study evaluated the dose intensity and toxicities experienced by patients of normal and increased body mass index BMI treated with FOLFOX chemo- therapy, and demonstrated that overweight patients may tolerate doses based on actual body weight.

Topics: News & Events Power & Sample Size

Brincidofovir a very-broad-spectrum antiviral drug?

Brincidofovir, or CMX001, is a broad-spectrum antiviral drug in development by Chimerix. The drug is presently in Phase 3 trials for life-threatening adenovirus in children and adults who have compromised immune systems and for adults with cytomegalovirus infections acquired after hematopoietic stem cells transplants for cancer.

Topics: News & Events

Johnson and Johnson to Start Ebola Vaccine Trial in 2015

Johnson & Johnson said that it will speed development of a new combination Ebola vaccine, with a clinical trial planned for early 2015. "The decision to accelerate the programme is based on the fact that it is such a catastrophic situation in West Africa," remarked chief scientific officer Paul Stoffels.

Topics: News & Events

GSK to start Clinical Trial on Ebola Vaccine

Glaxo Smith Kline will soon start a clinical trial on an experimental Ebola Vaccine against the deadly virus, which it is co-developing with U.S scientists.

Topics: News & Events

Clinical trial data to be made available for download.

Clinical trial data submitted for market authorization in the European Union must be made available for downloading for academic and non-commercial research purposes.

Clinical trial data submitted as part of marketing authorization applications in the European Union will be available for downloading, saving and printing for academic and non-commercial research purposes, the European Medicines Agency (EMA) has said.

Topics: News & Events

Generic versus brand name drugs

With more and more popular brand name drugs losing their patent protection in 2014, the generic versus brand name drugs debate is gaining momentum.

Topics: News & Events

Info-graphic: The process of discovering and bringing a new drug to the public

Great info-graphic from PPD on the process of discovering and bringing a new drug to the public which can typically cost a pharmaceutical or biotechnology company more than $1 billion and takes an average of 10 to 15 years!

Topics: News & Events